Scholl Hendrik Peter Insider Trading -- Recent SEC Form 4 Transactions
Scholl Hendrik Peter (CIK 2113223) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-10-05). Recent activity: Sell BLTE (200 shares), Sell BLTE (24 shares), Sell BLTE (120 shares), Sell BLTE (50 shares), Sell BLTE (78 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 200 | $32,725 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 24 | $3,951 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 120 | $19,859 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 50 | $8,322 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 78 | $13,072 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 12 | $2,019 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 14 | $2,371 |
| 2026-10-05 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 2 | $340 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 96 | $13,814 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 3,748 | $542,186 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 4,861 | $706,935 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,199 | $175,342 |
| 2026-06-22 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 96 | $14,123 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 2,054 | $282,651 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 784 | $108,333 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 3,140 | $438,250 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 540 | $75,913 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 100 | $14,183 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 450 | $63,990 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,897 | $272,314 |
| 2026-06-17 | BELITE BIO, INC (BLTE) | Chief Medical Officer | Sell | 1,035 | $150,096 |
Source: SEC Form 4 filings · as of 2026-10-05